Erratum: American college of critical care medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock (Critical Care Medicine (2017) 45 (1061-1093) DOI: 10.1097/CCM.0000000000002425);American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock

Critical Care Medicine

Volumn 45, Issue 6, 2017, Pages 1061-1093

  Davis, Alan L ^av   Carcillo, Joseph A ^a   Aneja, Rajesh K ^a   Deymann, Andreas J ^b   Lin, John C ^c   Nguyen, Trung C ^d   Okhuysen Cawley, Regina S ^d   Relvas, Monica S ^e   Rozenfeld, Ranna A ^f   Skippen, Peter W ^g   Stojadinovic, Bonnie J ^h   Williams, Eric A ⁱ   Yeh, Tim S ^j   Balamuth, Fran ^k   Brierley, Joe ^l   De Caen, Allan R ^m   Cheifetz, Ira M ⁿ   Choong, Karen ^o   Conway, Edward ^p   Cornell, Timothy ^q   Doctor, Allan ^c   Dugas, Marc Andre ^r   Feldman, Jonathan D ^s   Fitzgerald, Julie C ^k   Flori, Heidi R ^t   Fortenberry, James D ^u   Graciano, Ana Lia ^v   Greenwald, Bruce M ^w   Hall, Mark W ^x   Han, Yong Yun ^y   Hernan, Lynn J ^z   Irazuzta, Jose E ^aa   Iselin, Elizabeth ^ab   Van Der Jagt, Elise W ^ac   Jeffries, Howard E ^ad   Kache, Saraswati ^ae   Katyal, Chhavi ^af   Kissoon, Niranjan ^g   Kon, Alexander A ^ag   Kutko, Martha C ^ah   MacLaren, Graeme ^ai,aj,ak   Maul, Timothy ^al   Mehta, Renuka ^am   Odetola, Fola ^an   Parbuoni, Kristine ^ao   Paul, Raina ^f   Peters, Mark J ^l   Ranjit, Suchitra ^ap   Reuter Rice, Karin E ^aq   Schnitzler, Eduardo J ^ar   Scott, Halden F ^as   Torres, Adalberto ^at   Weingarten Abrams, Jacki ^af   Weiss, Scott L ^v   Zimmerman, Jerry J ^ad   Zuckerberg, Aaron L ^v,au   more..

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e TEXAS TECH UNIVERSITY   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j SAINT BARNABAS MEDICAL CENTER   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^m UNIVERSITY OF ALBERTA   (Canada)

ⁿ Division of Pulmonary and Critical Care Medicine   (United States)

^o MCMASTER CHILDREN S HOSPITAL   (Canada)

^p BETH ISRAEL MEDICAL CENTER   (United States)

^q UNIVERSITY OF MICHIGAN   (United States)

^r LAVAL UNIVERSITY   (Canada)

^s KAISER PERMANENTE   (United States)

^t UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^u EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^w WEILL CORNELL MEDICAL COLLEGE   (United States)

^x NATIONWIDE CHILDREN S HOSPITAL   (United States)

^y CHILDREN S MERCY HOSPITAL   (United States)

^z Texas Tech University Health Sciences Center El Paso   (United States)

^aa UNIVERSITY OF FLORIDA   (United States)

^ab Bon Secours St Mary's Hospital   (United States)

^ac UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^ad UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^ae STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^af ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^ag UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^ah VALLEY HOSPITAL   (United States)

^ai NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^aj ROYAL CHILDREN'S HOSPITAL   (Australia)

^ak UNIVERSITY OF MELBOURNE   (Australia)

^al CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^am MEDICAL COLLEGE OF GEORGIA   (United States)

^an UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^ao LOMA LINDA UNIVERSITY   (United States)

^ap Apollo Childrens Hospital   (India)

^aq DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ar UNIVERSIDAD AUSTRAL   (Argentina)

^as UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^at NEMOURS CHILDREN S HOSPITAL   (United States)

^au SINAI HOSPITAL OF BALTIMORE   (United States)

^av University of Colorado School of Medicine ^*

more..

Author keywords

Hemodynamics; Newborn; Pediatric; Septic shock

Indexed keywords

CALCIUM; CARDIOVASCULAR AGENT; GLUCOSE; HYDROCORTISONE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; THYROID HORMONE; VASODILATOR AGENT; BIOLOGICAL MARKER;

CLINICAL FEATURE; CLINICAL PRACTICE; CONTINUOUS RENAL REPLACEMENT THERAPY; EXTRACORPOREAL OXYGENATION; FLUID RESUSCITATION; HEMODYNAMICS; HEMOFILTRATION; HEMOPERFUSION; HORMONE SUBSTITUTION; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE; INTRAVASCULAR CATHETER; INTUBATION; INVASIVE PROCEDURE; META ANALYSIS; MINIMALLY INVASIVE PROCEDURE; NEWBORN CARE; PATIENT MONITORING; PEDIATRIC EMERGENCY MEDICINE; PLASMA EXCHANGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; REVIEW; SEDATION; SEPTIC SHOCK; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; VASCULAR ACCESS; ANESTHESIA; CARE BUNDLE; CHILD; FLUID THERAPY; MORTALITY; NEWBORN; PHYSIOLOGIC MONITORING; PROCEDURES; SHOCK, SEPTIC; STANDARDS; TIME FACTOR; UNITED STATES;

ANESTHESIA; BIOMARKERS; CARDIOVASCULAR AGENTS; CHILD; CRITICAL CARE; EXTRACORPOREAL MEMBRANE OXYGENATION; FLUID THERAPY; HEMODYNAMICS; HOSPITAL MORTALITY; HUMANS; INFANT, NEWBORN; MONITORING, PHYSIOLOGIC; PATIENT CARE BUNDLES; PRACTICE GUIDELINES AS TOPIC; RESUSCITATION; SHOCK, SEPTIC; TIME FACTORS; UNITED STATES;

EID: 85020376098     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002573     Document Type: Erratum

References (392)

1. Carcillo JA, Fields AI; American College of Critical Care Medicine Task Force Committee Members: Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002; 30:1365-1378
2. Brierley J, Carcillo JA, Choong K, et al: Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009; 37:666-688
3. Nhan NT, Phuong CXT, Kneen R, et al: Acute management of dengue shock syndrome: A randomized double-blind comparison of 4 intravenous fluid regimens in the first hour Clin Infect Dis 2001; 32:204-212
4. Booy R, Habibi P, Nadel S, et al; Meningococcal Research Group: Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001; 85:386-390
5. Kutko MC, Calarco MP, Flaherty MB, et al: Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med 2003; 4:333-337
6. DuPont HL, Spink WW: Infections due to gram-negative organisms: An analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 1969; 48:307-332
7. Stoll BJ, Holman RC, Shuchat A: Decline in sepsis-associated neonatal and infant deaths 1974-1994. Pediatrics 1998; 102:E18
8. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
9. Watson RS, Carcillo JA, Linde-Zwirble WT, et al: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695-701
10. Han YY, Carcillo JA, Dragotta MA, et al: Early reversal of pediatricneonatal septic shock by community physicians is associated with improved outcome. Pediatrics 2003; 112:793-799
11. Ninis N, Phillips C, Bailey L, et al: The role of healthcare delivery in the outcome of meningococcal disease in children: Case-control study of fatal and non-fatal cases. BMJ 2005; 330:1475
12. Ventura AM, Shieh HH, Bousso A, et al: Double-blind prospective randomized controlled trial of dopamine versus epinephrine as firstline vasoactive drugs in pediatric septic shock. Crit Care Med 2015; 43:2292-2302
13. de Oliveira CF, de Oliveira DS, Gottschald AF, et al: ACCM/PALS haemodynamic support guidelines for paediatric septic shock: An outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med 2008; 34:1065-1075
14. Sankar J, Sankar MJ, Suresh CP, et al: Early goal-directed therapy in pediatric septic shock: Comparison of outcomes "with" and "without" intermittent superior venacaval oxygen saturation monitoring: A prospective cohort study. Pediatr Crit Care Med 2014; 15:e157-e167
15. Karapinar B, Lin JC, Carcillo JA: ACCM guidelines use, correct antibiotic therapy, and immune suppressant withdrawal are associated with improved survival in pediatric sepsis, severe sepsis, and septic shock. Crit Care Med 2004; 32(12 Suppl 3):A161
16. Maat M, Buysse CM, Emonts M, et al: Improved survival of children with sepsis and purpura: Effects of age, gender, and era. Crit Care 2007; 11:R112
17. Wills BA, Nguyen MD, Ha TL, et al: Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005; 353:877-889
18. Maitland K, Kiguli S, Opoka RO, et al; FEAST Trial Group: Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364:2483-2495
19. Cruz AT, Perry AM, Williams EA, et al: Implementation of goal-directed therapy for children with suspected sepsis in the emergency department. Pediatrics 2011; 127:e758-e766
20. Larsen GY, Mecham N, Greenberg R: An emergency department septic shock protocol and care guideline for children initiated at triage. Pediatrics 2011; 127:e1585-e1592
21. Paul R, Neuman MI, Monuteaux MC, et al: Adherence to PALS Sepsis Guidelines and Hospital Length of Stay. Pediatrics 2012; 130:e273-e280
22. Paul R, Melendez E, Stack A, et al: Improving adherence to PALS septic shock guidelines. Pediatrics 2014; 133:e1358-e1366
23. Cruz AT, Williams EA, Graf JM, et al: Test characteristics of an automated age- and temperature-adjusted tachycardia alert in pediatric septic shock. Pediatr Emerg Care 2012; 28:889-894
24. Sepanski RJ, Godambe SA, Mangum CD, et al: Designing a pediatric severe sepsis screening tool. Front Pediatr 2014; 2:56
25. Han YY, Kissoon N, Carcillo JA, et al: The Global Pediatric Sepsis Initiative. Pediatr Crit Care Med 2014; 15(suppl):15-16
26. Hollenberg SM, Ahrens TS, Annane D, et al: Practice parameters for hemodynamic support of sepsis in adults patients: 2004 update. Crit Care Med 2004; 32:1928-1948
27. Parker MM, Shelhamer JH, Natanson C, et al: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis. Crit Care Med 1987; 15:923-929
28. Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490
29. Pollack MM, Fields AI, Ruttimann UE: Sequential cardiopulmonary variables of infants and children in septic shock. Crit Care Med 1984; 12:554-559
30. Pollack MM, Fields AI, Ruttimann UE: Distributions of cardiopulmonary variables in pediatric survivors and nonsurvivors of septic shock. Crit Care Med 1985; 13:454-459
31. Carcillo JA, Pollack MM, Ruttimann UE, et al: Sequential physiologic interactions in pediatric cardiogenic and septic shock. Crit Care Med 1989; 17:12-16
32. Monsalve F, Rucabado L, Salvador A, et al: Myocardial depression in septic shock caused by meningococcal infection. Crit Care Med 1984; 12:1021-1023
33. Mercier JC, Beaufils F, Hartmann JF, et al: Hemodynamic patterns of meningococcal shock in children. Crit Care Med 1988; 16:27-33
34. Simma B, Fritz MG, Trawöger R, et al: Changes in left ventricular function in shocked newborns. Intensive Care Med 1997; 23:982-986
35. Walther FJ, Siassi B, Ramadan NA, et al: Cardiac output in newborn infants with transient myocardial dysfunction. J Pediatr 1985; 107:781-785
36. Ferdman B, Jureidini SB, Gale G, et al: Severe left ventricular dysfunction and arrhythmias as complications of gram-positive sepsis: Rapid recovery in children. Pediatr Cardiol 1998; 19:482-486
37. Feltes TF, Pignatelli R, Kleinert S, et al: Quantitated left ventricular systolic mechanics in children with septic shock utilizing noninvasive wall-stress analysis. Crit Care Med 1994; 22:1647-1658
38. Ceneviva G, Paschall JA, Maffei F, et al: Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998; 102:e19
39. Brierly J, Thiruchelvan T, Peters MJ: Hemodynamics of early pediatric fluid resistant septic shock using non-invasive cardiac output (USCOM) distinct profiles of CVC infection and community acquired sepsis. Crit Care Med 2006; 33:171-I
40. Deep A, Goonasekera CD, Wang Y, et al: Evolution of haemodynamics and outcome of fluid-refractory septic shock in children. Intensive Care Med 2013; 39:1602-1609
41. Hoban LD, Paschall JA, Eckstein J, et al: Awake porcine model of intraperitoneal sepsis and altered oxygen utilization. Circ Shock 1991; 34:252-262
42. Green EM, Adams HR: New perspectives in circulatory shock: Pathophysiologic mediators of the mammalian response to endotoxemia and sepsis. J Am Vet Med Assoc 1992; 200:1834-1841
43. McDonough KH, Brumfield BA, Lang CH: In vitro myocardial performance after lethal and nonlethal doses of endotoxin. Am J Physiol 1986; 250:H240-H246
44. Natanson C, Fink MP, Ballantyne HK, et al: Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest 1986; 78:259-270
45. Dobkin ED, Lobe TE, Bhatia J, et al: The study of fecal E. coli peritonitis-induced septic shock in a neonatal pig model. Circ Shock 1985; 16:325-36
46. Peevy KJ, Chartrand SA, Wiseman HJ, et al: Myocardial dysfunction in group B streptococcal shock. Pediatr Res 1985; 19:511-513
47. Meadow WL, Meus PJ: Unsuspected mesenteric hypoperfusion despite apparent hemodynamic recovery in the early phase of septic shock in piglets. Circ Shock 1985; 15:123-129
48. Meadow WL, Meus PJ: Early and late hemodynamic consequences of group B beta streptococcal sepsis in piglets: Effects on systemic, pulmonary, and mesenteric circulations. Circ Shock 1986; 19:347-356
49. Gill AB, Weindling AM: Echocardiographic assessment of cardiac function in shocked very low birthweight infants. Arch Dis Child 1993; 68(1 Spec No):17-21
50. Kluckow M: Low systemic blood flow and pathophysiology of the preterm transitional circulation. Early Hum Dev 2005; 81:429-437
51. Munro MJ, Walker AM, Barfield CP: Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics 2004; 114:1591-1596
52. Jayasinghe D, Gill AB, Levene MI: CBF reactivity in hypotensive and normotensive preterm infants. Pediatr Res 2003; 54:848-853
53. 2 reactivity) is lost in hypotensive, ventilated, preterm infants. Pediatr Res 2004; 55:898
54. Al-Aweel I, Pursley DM, Rubin LP, et al: Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol 2001; 21:272-278
55. Martens SE, Rijken M, Stoelhorst GM, et al; Leiden Follow-Up Project on Prematurity, The Netherlands: Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants? Early Hum Dev 2003; 75:79-89
56. Subhedar NV: Treatment of hypotension in newborns. Semin Neonatol 2003; 8:413-423
57. Seri I, Noori S: Diagnosis and treatment of neonatal hypotension outside the transitional period. Early Hum Dev 2005; 81:405-411
58. Noori S, Seri I: Pathophysiology of newborn hypotension outside the transitional period. Early Hum Dev 2005; 81:399-404
59. Evans JR, Lou Short B, Van Meurs K, et al: Cardiovascular support in preterm infants. Clin Ther 2006; 28:1366-1384
60. Evans N: Which inotrope for which baby? Arch Dis Child Fetal Neonatal Ed 2006; 91:F213-220
61. Osborn DA: Diagnosis and treatment of preterm transitional circulatory compromise. Early Hum Dev 2005; 81:413-422
62. Evans N: Management of hypotension and circulatory assessment on NICU. Early Hum Dev 2005; 81:397-398
63. Seri I: Inotrope, lusitrope, and pressor use in neonates. J Perinatol 2005; 25(Suppl 2):S28-S30
64. Schönberger W, Grimm W, Gempp W, et al: Transient hypothyroidism associated with prematurity, sepsis, and respiratory distress. Eur J Pediatr 1979; 132:85-92
65. Roberton NR, Smith MA: Early neonatal hypocalcaemia. Arch Dis Child 1975; 50:604-609
66. Efird MM, Heerens AT, Gordon PV, et al: A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants. J Perinatol 2005; 25:119-124
67. Ng PC, Lee CH, Bnur FL, et al: A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treat ment of refractory hypotension in preterm infants. Pediatrics 2006; 117:367-375
68. Fernandez E, Schrader R, Watterberg K: Prevalence of low cortisol values in term and near-term infants with vasopressor-resistant hypotension. J Perinatol 2005; 25:114-118
69. Noori S, Siassi B, Durand M, et al: Cardiovascular effects of lowdose dexamethasone in very low birth weight neonates with refractory hypotension. Biol Neonate 2006; 89:82-87
70. Lauterbach R, Pawlik D, Kowalczyk D, et al: Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo-controlled, double-blind trial. Crit Care Med 1999; 27:807-814
71. Zimmerman JJ: Appraising the potential of pentoxifylline in septic premies. Crit Care Med 1999; 27:695-697
72. Haque K, Mohan P: Pentoxifylline for neonatal sepsis. Cochrane Database Syst Rev 2003; CD004205
73. Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1110-1116
74. Carcillo JA, Kuch BA, Han YY, et al: Mortality and functional morbidity after use of PALS/APLS by community physicians. Pediatrics 2009; 124:500-508
75. Ranjit S, Aram G, Kissoon N, et al: Multimodal monitoring for hemodynamic categorization and management of pediatric septic shock: A pilot observational study. Pediatr Crit Care Med 2014; 15:e17-e26
76. Kumar R, Singhi S, Singhi P, et al: Randomized controlled trial comparing cerebral perfusion pressure-targeted therapy versus intracranial pressure-targeted therapy for raised intracranial pressure due to acute CNS infections in children. Crit Care Med 2014; 42:1775-1787
77. Redl-Wenzl EM, Armbruster C, Edelmann G, et al: The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19:151-154
78. LeDoux D, Astiz ME, Carpati CM, et al: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28:2729-2732
79. Greenhalgh DG, Warden GD: The importance of intra-abdominal pressure measurements in burned children. J Trauma 1994; 36:685-690
80. Evans N, Osborn D, Kluckow M: Preterm circulatory support is more complex than just blood pressure. Pediatrics 2005; 115:1114-1115
81. Osborn DA, Evan N, Kluckow M: Clinical detection of low upper body blood flow in very premature infants using blood pressure, capillary refill time, and central - peripheral temperature difference Arch Dis Child Fetal Neonatal Ed 2004; 69:F168-F173
82. Hunt RW, Evans N, Rieger I, et al: Low superior vena cava flow and neurodevelopment at 3 years in very preterm infants. J Pediatr 2004; 145:588-592
83. Evans N, Kluckow M, Simmons M, et al: Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava blood flow in very preterm infants Arch Dis Child Fetal Neonatal Ed 2002; 87:F181-F184
84. Osborn DA, Evans N, Kluckow M: Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics 2003; 112:33-39
85. Osborn DA, Evans N, Kluckow M: Effect of targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2003; 88:F477-F482
86. Osborn D, Evans N, Kluckow M: Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr 2002; 140:183-191
87. Evans N, Osborn D, Kluckow M: Mechanism of blood pressure increase induced by dopamine in hypotensive preterm neonates. Arch Dis Child Fetal Neonatal Ed 2000; 83:F75-F76
88. Kluckow M, Evans N: Low systemic blood flow in the preterm infant. Semin Neonatol 2001; 6:75-84
89. Kluckow M, Evans N: Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000; 137:68-72
90. Kluckow M, Evans N: Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000; 82:F188-F194
91. Parr GV, Blackstone EH, Kirklin JW: Cardiac performance and mortality early after intracardiac surgery in infants and young children. Circulation 1975; 51:867-874
92. Yasaka Y, Khemani RG, Markovitz BP: Is shock index associated with outcome in children with sepsis/septic shock?. Pediatr Crit Care Med 2013; 14:e372-e379
93. Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
94. Textoris J, Fouché L, Wiramus S, et al: High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Crit Care 2011; 15:R176
95. Ahmad S, Tejuja A, Newman KD, et al: Clinical review: A review and analysis of heart rate variability and the diagnosis and prognosis of infection. Crit Care 2009; 13:232
96. Fenton KE, Sable CA, Bell MJ, et al: Increases in serum levels of troponin I are associated with cardiac dysfunction and disease severity in pediatric patients with septic shock. Pediatr Crit Care Med 2004; 5:533-538
97. Briassoulis G, Narlioglou M, Zavras N, et al: Myocardial injury in meningococcus-induced purpura fulminans in children. Intensive Care Med 2001; 27:1073-1082
98. Thiru Y, Pathan N, Bignall S, et al: A myocardial cytotoxic process is involved in the cardiac dysfunction of meningococcal septic shock. Crit Care Med 2000; 28:2979-2983
99. Hatherill M, Waggie Z, Purves L, et al: Mortality and the nature of metabolic acidosis in children with shock. Intensive Care Med 2003; 29:286-291
100. Dugas MA, Proulx F, de Jaeger A, et al: Markers of tissue hypoperfusion in pediatric septic shock. Intensive Care Med 2000; 26:75-83
101. Scott HF, Donoghue AJ, Gaieski DF, et al: The utility of early lactate testing in undifferentiated pediatric systemic inflammatory response syndrome. Acad Emerg Med 2012; 19:1276-1280
102. Kim YA, Ha EJ, Jhang WK, et al: Early blood lactate area as a prognostic marker in pediatric septic shock. Intensive Care Med 2013; 39:1818-1823
103. Jat KR, Jhamb U, Gupta VK: Serum lactate levels as the predictor of outcome in pediatric septic shock. Indian J Crit Care Med 2011; 15:102-107
104. James JH, Luchette FA, McCarter FD, et al: Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999; 354:505-508
105. Chapman LL, Sullivan B, Pacheco AL, et al: Vein Viewer-assisted intravenous catheter placement in a pediatric emergency department. Acad Emerg Med 2011; 18:966-971
106. Kim MJ, Park JM, Rhee N, et al: Efficacy of Vein Viewer in pediatric peripheral intravenous access: A randomized controlled trial. Eur J Pediatr 2012; 171:1121-1125
107. Aria DJ, Vatsky S, Kaye R, et al: Greater saphenous venous access as an alternative in children. Pediatr Radiol 2014; 44:187-192
108. Guilfoyle FJ, Milner R, Kissoon N: Resuscitation interventions in a tertiary level pediatric emergency department: Implications for maintenance of skills. CJEM 2011; 13:90-95
109. Kanter RK, Zimmerman JJ, Strauss RH, et al: Pediatric emergency intravenous access. Evaluation of a protocol. Am J Dis Child 1986; 140:132-134
110. Voigt J, Waltzman M, Lottenberg L: Intraosseous vascular access for in-hospital emergency use: A systematic clinical review of the literature and analysis. Pediatr Emerg Care 2012; 28:185-199
111. American Heart Association/American Academy of Pediatrics Pediatric Resuscitation Subcommittee: Pediatric Advanced Life Support Provider Manual. Oak Park, IL, AHA/AAP, 2010, p 110
112. Fiorito BA, Mirza F, Doran TM, et al: Intraosseous access in the setting of pediatric critical care transport. Pediatr Crit Care Med 2005; 6:50-53
113. National Institute for Clinical Excellence: Guidance on the Use of Ultrasound Locating Devices for Placing Central Venous Catheters. Technology Appraisal Guidance No. 49, 2002
114. Verghese ST, McGill WA, Patel RI, et al: Ultrasound-guided internal jugular venous cannulation in infants: A prospective comparison with the traditional palpation method. Anesthesiology 1999; 91:71-77
115. Ultrasound guidance of central vein catheterization. In: Rothschild JM (Eds). Evidence Report/Technology Assessment, No. 43. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Rockville, MD, Agency for Healthcare Research and Quality, 2001, Publication No. 01-E058, 245-53
116. Di Nardo M, Tomasello C, Pittiruti M, et al: Ultrasound-guided central venous cannulation in infants weighing less than 5 kilograms. J Vasc Access 2011; 12:321-324
117. Hind D, Calvert N, McWilliams R, et al: Ultrasonic locating devices for central venous cannulation: Meta-analysis. BMJ 2003; 327:361
118. Lamperti M, Caldiroli D, Cortellazzi P, et al: Safety and efficacy of ultrasound assistance during internal jugular vein cannulation in neurosurgical infants. Intensive Care Med 2008; 34:2100-2105
119. Sigaut S, Skhiri A, Stany I, et al: Ultrasound guided internal jugular vein access in children and infant: A meta-analysis of published studies. Paediatr Anaesth 2009; 19:1199-1206
120. Ngo NT, Cao XT, Kneen R, et al: Acute management of dengue shock syndrome: A randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001; 32:204-213
121. Dung NM, Day NP, Tam DT, et al: Fluid replacement in dengue shock syndrome: A randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 1999; 29:787-794
122. Maitland K, Pamba A, English M, et al: Randomized trial of volume expansion with albumin or saline in children with severe malaria: Preliminary evidence of albumin benefit. Clin Infect Dis 2005; 40:538-545
123. Finfer S, Bellomo R, Boyce N, et al; SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256
124. Upadhyay M, Singhi S, Murlidharan J, et al: Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatr 2005; 42:223-231
125. Carcillo JA, Davis AL, Zaritsky A: Role of early fluid resuscitation in pediatric septic shock. JAMA 1991; 266:1242-1245
126. Stoner MJ, Goodman DG, Cohen DM, et al: Rapid fluid resuscitation in pediatrics; testing the ACCM guidelines Crit Care Med 2005; 33:A68
127. Ranjit S, Kissoon N, Jayakumar I: Aggressive management of dengue shock syndrome may decrease mortality rate: A suggested protocol. Pediatr Crit Care Med 2005; 6:412-419
128. Foland JA, Fortenberry JD, Warshaw BL, et al: Fluid overload before continuous hemofiltration and survival in critically ill children: A retrospective analysis. Crit Care Med 2004; 32:1771-1776
129. Lucking SE, Williams TM, Chaten FC, et al: Dependence of oxygen consumption on oxygen delivery in children with hyperdynamic septic shock and low oxygen extraction. Crit Care Med 1990; 18:1316-1319
130. Mink RB, Pollack MM: Effect of blood transfusion on oxygen consumption in pediatric septic shock. Crit Care Med 1990; 18:1087-1091
131. Karam O, Tucci M, Ducruet T, et al; Canadian Critical Care Trials Group; PALISI Network: Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatr Crit Care Med 2011; 12:512-518
132. Carroll GC, Snyder JV: Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 1982; 243:R131-R141
133. Lee PK, Deringer JR, Kreiswirth BN, et al: Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins. Infect Immun 1991; 59:879-884
134. Ottoson J, Dawidson I, Brandberg A, et al: Cardiac output and organ blood flow in experimental septic shock: Effect of treatment with antibiotics, corticosteroids, and fluid infusion. Circ Shock 1991; 35:14-24
135. Wilson MA, Chou MC, Spain DA, et al: Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis. J Trauma 1996; 41:622-627
136. Boldt J, Muller M, Heesen M: Influence of different volume therapies and pentoxifylline infusion on circulating adhesion molecules in critically ill patients. Crit Care Med 1998; 24:385-391
137. Zadrobilek E, Hackl W, Sporn P, et al: Effect of large volume replacement with balanced electrolyte solutions on extravascular lung water in surgical patients with sepsis syndrome. Intensive Care Med 1989; 15:505-510
138. Powell KR, Sugarman LI, Eskenazi AE, et al: Normalization of plasma arginine vasopressin concentrations when children with meningitis are given maintenance plus replacement fluid therapy. J Pediatr 1990; 117:515-522
139. Pladys P, Wodey E, Bétrémieux P, et al: Effects of volume expansion on cardiac output in the preterm infant. Acta Paediatr 1997; 86:1241-1245
140. Lambert HJ, Baylis PH, Coulthard MG: Central-peripheral temperature difference, blood pressure, and arginine vasopressin in preterm neonates undergoing volume expansion. Arch Dis Child Fetal Neonatal Ed 1998; 78:F43-F45
141. Bressack MA, Morton NS, Hortop J: Group B streptococcal sepsis in the piglet: Effects of fluid therapy on venous return, organ edema, and organ blood flow. Circ Res 1987; 61:659-669
142. Pollard AJ, Britto J, Nadel S, et al: Emergency management of meningococcal disease. Arch Dis Child 1999; 80:290-296
143. Boldt J, Heesen M, Welters I, et al: Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Br J Anaesth 1995; 75:740-746
144. Oca MJ, Nelson M, Donn SM: Randomized trial of normal saline versus 5% albumin for the treatment of neonatal hypotension. J Perinatol 2003; 23:473-476
145. Cam BV, Tuan DT, Fonsmark L, et al: Randomized comparison of oxygen mask treatment vs nasal continuous positive airway pressure in dengue shock syndrome with acute respiratory failure. J Trop Pediatr 2002; 48:335-339
146. Maitland K, Pamba A, English M, et al: Pre-transfusion management of children with severe malarial anaemia: A randomised controlled trial of intravascular volume expansion. Br J Haematol 2005; 128:393-400
147. Liet JM, Kuster A, Denizot S, et al: Effects of hydroxyethyl starch on cardiac output in hypotensive neonates: A comparison with isotonic saline and 5% albumin. Acta Paediatr 2006; 95:555-560
148. Pamba A, Maitland K: Capillary refill: Prognostic value in Kenyan children. Arch Dis Child 2004; 89:950-955
149. Yamamoto LG: Rapid sequence intubation. In: Textbook of Pediatric Emergency Care. Ludwig S and Fleisher GR (Eds). Philadelphia, PA, Lippincott Williams and Wilkins, 2000
150. Jabre P, Avenel A, Combes X, et al: Morbidity related to emergency endotracheal intubation-a substudy of the KETAmine SEDation trial. Resuscitation 2011; 82:517-522
151. Haubner LY, Barry JS, Johnston LC, et al: Neonatal intubation performance: Room for improvement in tertiary neonatal intensive care units. Resuscitation 2013; 84:1359-1364
152. Li S, Rehder K, Giuliano JS, et al: Development of a quality improvement bundle to reduce tracheal intubation-associated events in PICUs. Am J Med Qual 2016; 31:47-55
153. Jones P, Dauger S, Denjoy I, et al: The effect of atropine on rhythm and conduction disturbances during 322 critical care intubations. Pediatr Crit Care Med 2013; 14:e289-e297
154. Jabre P, Combes X, Lapostolle F, et al; KETASED Collaborative Study Group: Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: A multicentre randomised controlled trial. Lancet 2009; 374:293-300
155. Barois J, Tourneux P: Ketamine and atropine decrease pain for preterm newborn tracheal intubation in the delivery room: An observational pilot study. Acta Paediatr 2013; 102:e534-e538
156. Cuthbertson BH, Sprung CL, Annane D, et al: The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009; 35:1868-1876
157. den Brinker M, Hokken-Koelega AC, Hazelzet JA, et al: One single dose of etomidate negatively influences adrenocortical performance for at least 24h in children with meningococcal sepsis. Intensive Care Med 2008; 34:163-168
158. Albert SG, Ariyan S, Rather A: The effect of etomidate on adrenal function in critical illness: A systematic review. Intensive Care Med 2011; 37:901-910
159. Dmello D, Taylor S, O'Brien J, et al: Outcomes of etomidate in severe sepsis and septic shock. Chest 2010; 138:1327-1332
160. McPhee LC, Badawi O, Fraser GL, et al: Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: Analysis of a large electronic ICU database. Crit Care Med 2013; 41:774-783
161. Nemergut ME, Yaster M, Colby CE: Sedation and analgesia to facilitate mechanical ventilation. Clin Perinatol 2013; 40:539-558
162. Hall RW: Anesthesia and analgesia in the NICU. Clin Perinatol 2012; 39:239-254
163. Sloth E, Pedersen J, Olsen KH, et al: Transoesophageal echocardiographic monitoring during paediatric cardiac surgery: Obtainable information and feasibility in 532 children. Paediatr Anaesth 2001; 11:657-662
164. Fernandez EG, Green TP, Sweeney M: Low inferior vena caval catheters for hemodynamic and pulmonary function monitoring in pediatric critical care patients. Pediatr Crit Care Med 2004; 5:14-18
165. Mahajan A, Shabanie A, Turner J, et al: Pulse contour analysis for cardiac output monitoring in cardiac surgery for congenital heart disease. Anesth Analg 2003; 97:1283-1288
166. Torgay A, Pirat A, Akpek E, et al: Pulse contour cardiac output system use in pediatric orthotopic liver transplantation: Preliminary report of nine patients. Transplant Proc 2005; 37:3168-3170
167. Reynolds EM, Ryan DP, Sheridan RL, et al: Left ventricular failure complicating severe pediatric burn injuries. J Pediatr Surg 1995; 30:264-269
168. Zaritsky A: Curr Concepts Ped Emergency and Crit Care 1998
169. Duke TD, Butt W, South M: Predictors of mortality and multiple organ failure in children with sepsis. Intensive Care Med 1997; 23:684-692
170. Tibby SM, Hatherill M, Marsh MJ, et al: Clinical validation of cardiac output measurements using femoral artery thermodilution with direct Fick in ventilated children and infants. Intensive Care Med 1997; 23:987-991
171. McLuckie A, Murdoch IA, Marsh MJ, et al: A comparison of pulmonary and femoral artery thermodilution cardiac indices in paediatric intensive care patients. Acta Paediatr 1996; 85:336-338
172. Pauli C, Fakler U, Genz T, et al: Cardiac output determination in children: Equivalence of the transpulmonary thermodilution method to the direct Fick principle. Intensive Care Med 2002; 28:947-952
173. Bollaert PE, Bauer P, Audibert G, et al: Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 1990; 98:949-953
174. Heckmann M, Trotter A, Pohlandt F, et al: Epinephrine treatment of hypotension in very low birthweight infants. Acta Paediatr 2002; 91:566-570
175. Pellicer A, Valverde E, Elorza MD, et al: Cardiovascular support for low birth weight infants and cerebral hemodynamics: A randomized, blinded, clinical trial. Pediatrics 2005; 115:1501-1512
176. Valverde E, Pellicer A, Madero R, et al: Dopamine versus epinephrine for cardiovascular support in low birth weight infants: Analysis of systemic effects and neonatal clinical outcomes. Pediatrics 2006; 117:e1213-e1222
177. Meier-Hellmann A, Reinhart K, Bredle DL, et al: Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997; 25:399-404
178. Subhedar NV, Shaw NJ: Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev 2003; CD001242
179. Sakr Y, Reinhart K, Vincent JL, et al: Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006; 34:589-597
180. Padbury JF, Agata Y, Baylen BG, et al: Pharmacokinetics of dopamine in critically ill newborn infants. J Pediatr 1990; 117:472-476
181. Bhatt-Mehta V, Nahata MC, McClead RE, et al: Dopamine pharmacokinetics in critically ill newborn infants. Eur J Clin Pharmacol 1991; 40:593-597
182. Allen E, Pettigrew A, Frank D, et al: Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children. Crit Care Med 1997; 25:181-189
183. Outwater KM, Treves ST, Lang P, et al: Renal and hemodynamic effects of dopamine in infants following cardiac surgery. J Clin Anesth 1990; 2:253-257
184. Lobe TE, Paone R, Dent SR, et al: Benefits of high-dose dopamine in experimental neonatal septic shock. J Surg Res 1987; 42:665-674
185. Seri I, Tulassay T, Kiszel J, et al: Cardiovascular response to dopamine in hypotensive preterm neonates with severe hyaline membrane disease. Eur J Pediatr 1984; 142:3-9
186. Padbury JF, Agata Y, Baylen BG, et al: Dopamine pharmacokinetics in critically ill newborn infants. J Pediatr 1987; 110:293-298
187. Hentschel R, Hensel D, Brune T, et al: Impact on blood pressure and intestinal perfusion of dobutamine or dopamine in hypotensive preterm infants. Biol Neonate 1995; 68:318-324
188. Klarr JM, Faix RG, Pryce CJ, et al: Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome. J Pediatr 1994; 125:117-122
189. Liet JM, Boscher C, Gras-Leguen C, et al: Dopamine effects on pulmonary artery pressure in hypotensive preterm infants with patent ductus arteriosus. J Pediatr 2002; 140:373-375
190. Kim KK, Frankel LR: The need for inotropic support in a subgroup of infants with severe life-threatening respiratory syncytial viral infection. J Investig Med 1997; 45:469-473
191. Jardin F, Eveleigh MC, Gurdjian F, et al: Venous admixture in human septic shock: Comparative effects of blood volume expansion, dopamine infusion and isoproterenol infusion on mismatching of ventilation and pulmonary blood flow in peritonitis. Circulation 1979; 60:155-159
192. Harada K, Tamura M, Ito T, et al: Effects of low-dose dobutamine on left ventricular diastolic filling in children. Pediatr Cardiol 1996; 17:220-225
193. Stopfkuchen H, Schranz D, Huth R, et al: Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals. Eur J Pediatr 1987; 146:135-139
194. Stopfkuchen H, Queisser-Luft A, Vogel K: Cardiovascular responses to dobutamine determined by systolic time intervals in preterm infants. Crit Care Med 1990; 18:722-724
195. Habib DM, Padbury JF, Anas NG, et al: Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. Crit Care Med 1992; 20:601-608
196. Berg RA, Donnerstein RL, Padbury JF: Dobutamine infusions in stable, critically ill children: Pharmacokinetics and hemodynamic actions. Crit Care Med 1993; 21:678-686
197. Martinez AM, Padbury JF, Thio S: Dobutamine pharmacokinetics and cardiovascular responses in critically ill neonates. Pediatrics 1992; 89:47-51
198. Perkin RM, Levin DL, Webb R, et al: Dobutamine: A hemodynamic evaluation in children with shock. J Pediatr 1982; 100:977-983
199. Goto M, Griffin A: Adjuvant effects of beta-adrenergic drugs on indomethacin treatment of newborn canine endotoxic shock. J Pediatr Surg 1991; 26:1156-1160
200. Clark SJ, Yoxall CW, Subhedar NV: Right ventricular performance in hypotensive preterm neonates treated with dopamine. Pediatr Cardiol 2002; 23:167-170
201. Lopez SL, Leighton JO, Walther FJ: Supranormal cardiac output in the dopamine- and dobutamine-dependent preterm infant. Pediatr Cardiol 1997; 18:292-296
202. Keeley SR, Bohn DJ: The use of inotropic and afterload-reducing agents in neonates. Clin Perinatol 1988; 15:467-489
203. Butt W, Bohn D, Whyte H: Clinical experience with systemic vasodilator therapy in the newborn infant. Aust Paediatr J 1986; 22:117-120
204. Benitz WE, Rhine WD, Van Meurs KP, et al: Nitrovasodilator therapy for severe respiratory distress syndrome. J Perinatol 1996; 16:443-448
205. Wong AF, McCulloch LM, Sola A: Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates. J Pediatr 1992; 121:980-983
206. Bailey JM, Miller BE, Kanter KR, et al: A comparison of the hemodynamic effects of amrinone and sodium nitroprusside in infants after cardiac surgery. Anesth Analg 1997; 84:294-298
207. Laitinen P, Happonen JM, Sairanen H, et al: Amrinone versus dopamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect. J Cardiothorac Vasc Anesth 1997; 11:870-874
208. Spronk PE, Ince C, Gardien MJ, et al: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360:1395-1396
209. Heyderman RS, Klein NJ, Shennan GI, et al: Deficiency of prostacyclin production in meningococcal shock. Arch Dis Child 1991; 66:1296-1299
210. Lauterbach R, Zembala M: Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr 1996; 155:404-409
211. Kawczynski P, Piotrowski A: Circulatory and diuretic effects of dopexamine infusion in low-birth-weight infants with respiratory failure. Intensive Care Med 1996; 22:65-70
212. Habre W, Beghetti M, Roduit C, et al: Haemodynamic and renal effects of dopexamine after cardiac surgery in children. Anaesth Intensive Care 1996; 24:435-439
213. Moffett BS, Orellana R: Use of fenoldopam to increase urine output in a patient with renal insufficiency secondary to septic shock: A case report. Pediatr Crit Care Med 2006; 7:600-602
214. Morelli A, Rocco M, Conti G, et al: Effects of short-term fenoldopam infusion on gastric mucosal blood flow in septic shock. Anesthesiology 2004; 101:576-582
215. Barton P, Garcia J, Kouatli A, et al: Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996; 109:1302-1312
216. Chang AC, Atz AM, Wernovsky G, et al: Milrinone: Systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995; 23:1907-1914
217. Matejovic M, Krouzecky A, Radej J, et al: Successful reversal of resistent hypodynamic septic shock with levosimendan. Acta Anaesthesiol Scand 2005; 49:127-128
218. Noto A, Giacomini M, Palandi A, et al: Levosimendan in septic cardiac failure. Intensive Care Med 2005; 31:164-165
219. Oldner A, Konrad D, Weitzberg E, et al: Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 2001; 29:2185-2193
220. Morelli A, Teboul JL, Maggiore SM, et al: Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study. Crit Care Med 2006; 34:2287-2293
221. Müller K, Peters A, Zeus T, et al: [Therapy of acute decompensated heart failure with levosimendan]. Med Klin (Munich) 2006; 101(Suppl 1):119-122
222. Namachivayam P, Crossland DS, Butt WW, et al: Early experience with Levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med 2006; 7:445-448
223. Ringe HI, Varnholt V, Gaedicke G: Cardiac rescue with enoximone in volume and catecholamine refractory septic shock. Pediatr Crit Care Med 2003; 4:471-475
224. Kern H, Schröder T, Kaulfuss M, et al: Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 2001; 29:1519-1525
225. Hoang P, Fosse JP, Fournier JL, et al: [Enoximone-noradrenaline combination in septic shock]. Presse Med 1991; 20:1785
226. Meadows D, Edwards JD, Wilkins RG, et al: Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663-666
227. Desjars P, Pinaud M, Potel G, et al: A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15:134-137
228. Morimatsu H, Singh K, Uchino S, et al: Early and exclusive use of norepinephrine in septic shock. Resuscitation 2004; 62:249-254
229. Hall LG, Oyen LJ, Taner CB, et al: Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy 2004; 24:1002-1012
230. Lampin ME, Rousseaux J, Botte A, et al: Noradrenaline use for septic shock in children: Doses, routes of administration and complications. Acta Paediatr 2012; 101:e426-e430
231. Tourneux P, Rakza T, Abazine A, et al: Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants. Acta Paediatr 2008; 97:177-180
232. Klinzing S, Simon M, Reinhart K, et al: High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003; 31:2646-2650
233. Delmas A, Leone M, Rousseau S, et al: Clinical review: Vasopressin and terlipressin in septic shock patients. Crit Care 2005; 9:212-222
234. Leibovitch L, Efrati O, Vardi A, et al: Intractable hypotension in septic shock: Successful treatment with vasopressin in an infant. Isr Med Assoc J 2003; 5:596-598
235. Matok I, Vard A, Efrati O, et al: Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 2005; 23:305-310
236. Tsuneyoshi I, Yamada H, Kakihana Y, et al: Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29:487-493
237. Peters MJ, Booth RA, Petros AJ: Terlipressin bolus induces systemic vasoconstriction in septic shock. Pediatr Crit Care Med 2004; 5:112-115
238. Liedel JL, Meadow W, Nachman J, et al: Use of vasopressin in refractory hypotension in children with vasodilatory shock: Five cases and a review of the literature. Pediatr Crit Care Med 2002; 3:15-18
239. Vasudevan A, Lodha R, Kabra SK: Vasopressin infusion in children with catecholamine-resistant septic shock. Acta Paediatr 2005; 94:380-383
240. Rodríguez-Núñez A, Fernández-Sanmartín M, Martinón-Torres F, et al: Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004; 30:477-480
241. Matok I, Leibovitch L, Vardi A, et al: Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004; 5:116-118
242. Rosenzweig EB, Starc TJ, Chen JM, et al: Intravenous argininevasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999; 100(Suppl 19):II182-II186
243. Agrawal A, Singh VK, Varma A, et al: Intravenous arginine vasopressin infusion in refractory vasodilatory shock: A clinical study. Indian J Pediatr 2012; 79:488-493
244. Bidegain M, Greenberg R, Simmons C, et al: Vasopressin for refractory hypotension in extremely low birth weight infants. J Pediatr 2010; 157:502-504
245. Meyer S, Gottschling S, Baghai A, et al: Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care 2006; 10:R71
246. Meyer S, Löffler G, Polcher T, et al: Vasopressin in catecholamine resistant septic and cardiogenic shock in very-low-birthweight infants. Acta Paediatr 2006; 95:1309-1312
247. Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
248. Choong K, Bohn D, Fraser DD, et al; Canadian Critical Care Trials Group: Vasopressin in pediatric vasodilatory shock: A multicenter randomized controlled trial. Am J Respir Crit Care Med 2009; 180:632-639
249. Zeballos G, López-Herce J, Fernández C, et al: Rescue therapy with terlipressin by continuous infusion in a child with catecholamine resistant septic shock. Resuscitation 2006; 68:151-153
250. Radicioni M, Troiani S, Camerini PG: Effects of terlipressin on pulmonary artery pressure in a septic cooled infant: An echocardiographic assessment. J Perinatol 2012; 32:893-895
251. Filippi L, Gozzini E, Daniotti M, et al: Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants. Pediatr Crit Care Med 2011; 12:e237-e241
252. Filippi L, Poggi C, Serafini L, et al: Terlipressin as rescue treatment of refractory shock in a neonate. Acta Paediatr 2008; 97:500-502
253. Leone M, Martin C: Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock. Best Pract Res Clin Anaesthesiol 2008; 22:323-333
254. Michel F, Thomachot L, David M, et al: Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock. Am J Emerg Med 2007; 25:863.e1-863.e2
255. Papoff P, Mancuso M, Barbara CS, et al: The role of terlipressin in pediatric septic shock: A review of the literature and personal experience. Int J Immunopathol Pharmacol 2007; 20:213-221
256. Rodríguez-Núñez A, Oulego-Erroz I, Gil-Antón J, et al; RETSPED-II Working Group of the Spanish Society of Pediatric Intensive Care: Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock. Ann Pharmacother 2010; 44:1545-1553
257. Rodríguez-Núñez A, López-Herce J, Gil-Antón J, et al; RETSPED Working Group of the Spanish Society of Pediatric Intensive Care: Rescue treatment with terlipressin in children with refractory septic shock: A clinical study. Crit Care 2006; 10:R20
258. Yildizdas D, Yapicioglu H, Celik U, et al: Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med 2008; 34:511-517
259. Yunge M, Petros A: Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child 2000; 82:388-389
260. Gregory JS, Bonfiglio MF, Dasta JF, et al: Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 1991; 19:1395-1400
261. López A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30
262. Grover R, Lopez A, Lorente J et al Multi-center, randomized, double blind, placebo-controlled, double bind study of nitric oxide inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 1999; 27:A33
263. Driscoll W, Thurin S, Carrion V, et al: Effect of methylene blue on refractory neonatal hypotension. J Pediatr 1996; 129:904-908
264. Taylor K, Holtby H: Methylene blue revisited: Management of hypotension in a pediatric patient with bacterial endocarditis. J Thorac Cardiovasc Surg 2005; 130:566
265. Faustino EV, Bogue CW: Relationship between hypoglycemia and mortality in critically ill children. Pediatr Crit Care Med 2010; 11:690-698
266. Wintergerst KA, Buckingham B, Gandrud L, et al: Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006; 118:173-179
267. Branco RG, Garcia PC, Piva JP, et al: Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med 2005; 6:470-472
268. Day KM, Haub N, Betts H, et al: Hyperglycemia is associated with morbidity in critically ill children with meningococcal sepsis. Pediatr Crit Care Med 2008; 9:636-640
269. Mesotten D, Gielen M, Sterken C, et al: Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: A randomized controlled trial. JAMA 2012; 308:1641-1650
270. Macrae D, Grieve R, Allen E, et al; CHiP Investigators: A randomized trial of hyperglycemic control in pediatric intensive care. N Engl J Med 2014; 370:107-118
271. Agus MSD, Stiel GM, Wypij D, et al: Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012; 367; 1208-1219
272. Vlasselaers D, Milants I, Desmet L, et al: Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009; 373:547-556
273. Rigby M, Maher K, Preissig C, et al: The Pedietrol trial: A 2-center trial of glycemic control in pediatric critical illness. Crit Care Med 2013; 41:A993
274. Verhoeven JJ, den Brinker M, Hokken-Koelega AC, et al: Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: A prospective, observational cohort study. Crit Care 2011; 15:R44
275. van Waardenburg DA, Jansen TC, Vos GD, et al: Hyperglycemia in children with meningococcal sepsis and septic shock: The relation between plasma levels of insulin and inflammatory mediators. J Clin Endocrinol Metab 2006; 91:3916-3921
276. Annane D, Sébille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
277. Hodes HL: Care of the critically ill child: Endotoxin shock. Pediatrics 1969; 44:248-260
278. Sonnenschein H, Joos HA: Use and dosage of hydrocortisone in endotoxic shock. Pediatrics 1970; 45:720
279. Migeon CJ, Kenny FM, Hung W, et al: Study of adrenal function in children with meningitis. Pediatrics 1967; 40:163-183
280. Soni A, Pepper GM, Wyrwinski PM, et al: Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995; 98:266-271
281. Riordan FA, Thomson AP, Ratcliffe JM, et al: Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency? Crit Care Med 1999; 27:2257-2261
282. Sumarmo: The role of steroids in dengue shock syndrome. Southeast Asian J Trop Med Public Health 1987; 18:383-389
283. Min M, U T, Aye M, et al: Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health 1975; 6:573-579
284. Hatherill M, Tibby SM, Hilliard T, et al: Adrenal insufficiency in septic shock. Arch Dis Child 1999; 80:51-55
285. Ryan CA, Wenman W, Henningsen C, et al: Fatal childhood pneumococcal Waterhouse-Friderichsen syndrome. Pediatr Infect Dis J 1993; 12:250-251
286. Matot I, Sprung CL. Corticosteroids in septic shock: Resurrection of the last rites? Crit Care Med 1998; 26:627-630
287. Briegel J, Forst H, Kellermann W, et al: Haemodynamic improvement in refractory septic shock with cortisol replacement therapy. Intensive Care Med 1992; 18:318
288. Moran JL, Chapman MJ, O'Fathartaigh MS, et al: Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 1994; 20:489-495
289. Todd JK, Ressman M, Caston SA, et al: Corticosteroid therapy for patients with toxic shock syndrome. JAMA 1984; 252:3399-3402
290. Sonnenschein H, Joos HA: Hydrocortisone treatment of endotoxin shock. Another paradox in pediatrics. Clin Pediatr (Phila) 1970; 9:251-252
291. Bettendorf M, Schmidt KG, Grulich-Henn J, et al: Tri-iodothyronine treatment in children after cardiac surgery: A double-blind, randomised, placebo-controlled study. Lancet 2000; 356:529-534
292. Joosten KF, de Kleijn ED, Westerterp M, et al: Endocrine and metabolic responses in children with meningoccocal sepsis: Striking differences between survivors and nonsurvivors. J Clin Endocrinol Metab 2000; 85:3746-3753
293. Menon K, Ward RE, Lawson ML, et al; Canadian Critical Care Trials Group: A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med 2010; 182:246-251
294. Marquardt DJ, Knatz NL, Wetterau LA, et al: Failure to recover somatotropic axis function is associated with mortality from pediatric sepsis-induced multiple organ dysfunction syndrome. Pediatr Crit Care Med 2010; 11:18-25
295. Indyk JA, Candido-Vitto C, Wolf IM, et al: Reduced glucocorticoid receptor protein expression in children with critical illness. Horm Res Paediatr 2013; 79:169-178
296. Boonen E, Vervenne H, Meersseman P, et al: Reduced cortisol metabolism during critical illness. N Engl J Med 2013; 368:1477-1488
297. Annane D, Bellissant E, Bollaert PE, et al: Corticosteroids in the treatment of severe sepsis and septic shock in adults: A systematic review. JAMA 2009; 301:2362-2375
298. Wheeler DS, Zingarelli B, Wheeler WJ, et al: Novel pharmacologic approaches to the management of sepsis: Targeting the host inflammatory response. Recent Pat Inflamm Allergy Drug Discov 2009; 3:96-112
299. Oppert M, Schindler R, Husung C, et al: Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005; 33:2457-2464
300. Sarthi M, Lodha R, Vivekanandhan S, et al: Adrenal status in children with septic shock using low-dose stimulation test. Pediatr Crit Care Med 2007; 8:23-28
301. Sam S, Corbridge TC, Mokhlesi B, et al: Cortisol levels and mortality in severe sepsis. Clin Endocrinol (Oxf) 2004; 60:29-35
302. Menon K, McNally D, Choong K, et al: A systematic review and meta-analysis on the effect of steroids in pediatric shock. Pediatr Crit Care Med 2013; 14:474-480
303. Zimmerman JJ, Donaldson A, Barker RM, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network: Real-time free cortisol quantification among critically ill children. Pediatr Crit Care Med 2011; 12:525-531
304. Hamrahian AH, Oseni TS, Arafah BM: Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350:1629-1638
305. Cotton BA, Guillamondegui OD, Fleming SB, et al: Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients. Arch Surg 2008; 143:62-67
306. Li J, Winkler M: Decompensated septic shock in the setting of megace-induced severe adrenal suppression in an otherwise healthy pediatric patient: A case report. Pediatr Emerg Care 2012; 28:802-804
307. Jeschke MG, Williams FN, Finnerty CC, et al: The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes. PLoS One 2012; 7:e35465
308. Aneja R, Carcillo JA: What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock? Arch Dis Child 2007; 92:165-169
309. Marik PE, Pastores SM, Annane D, et al; American College of Critical Care Medicine: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36:1937-1949
310. Annane D, Maxime V, Ibrahim F, et al: Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174:1319-1326
311. Lichtarowicz-Krynska EJ, Cole TJ, Camacho-Hubner C, et al: Circulating aldosterone levels are unexpectedly low in children with acute meningococcal disease. J Clin Endocrinol Metab 2004; 89:1410-1414
312. Hebbar KB, Stockwell JA, Fortenberry JD: Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children. Intensive Care Med 2011; 37:518-524
313. Arafah BM: Hypothalamic pituitary adrenal function during critical illness: Limitations of current assessment methods. J Clin Endocrinol Metab 2006; 91:3725-3745
314. Jung C, Inder WJ: Management of adrenal insufficiency during the stress of medical illness and surgery. Med J Aust 2008; 188:409-413
315. Padidela R, Hindmarsh PC: Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010; 2010:656925
316. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
317. Lodygensky GA, Rademaker K, Zimine S, et al: Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics 2005; 116:1-7
318. Baker CF, Barks JD, Engmann C, et al: Hydrocortisone administration for the treatment of refractory hypotension in critically ill newborns. J Perinatol 2008; 28:412-419
319. Burmester M, Pierce C, Petros A: Disseminated candidiasis after steroid treatment for early neonatal hypotension. Arch Dis Child Fetal Neonatal Ed 2001; 85:F226
320. Wong HR, Cvijanovich NZ, Allen GL, et al: Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock. Am J Respir Crit Care Med 2014; 189:940-946
321. Zimmerman JJ, Williams MD: Adjunctive corticosteroid therapy in pediatric severe sepsis: Observations from the RESOLVE study. Pediatr Crit Care Med 2011; 12:2-8
322. Esteban NV, Loughlin T, Yergey AL, et al: Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991; 72:39-45
323. Kerrigan JR, Veldhuis JD, Leyo SA, et al: Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 1993; 76:1505-1510
324. Kenny FM, Preeyasombat C, Migeon CJ: Cortisol production rate. II. Normal infants, children, and adults. Pediatrics 1966; 37:34-42
325. Kenny FM, Malvaux P, Migeon CJ: Cortisol production rate in newborn babies, older infants, and children. Pediatrics 1963; 31:360-373
326. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
327. Pizarro CF, Troster EJ: Adrenal function in sepsis and septic shock. J Pediatr (Rio J) 2007; 83(5 Suppl):S155-S162
328. Roberts JD Jr, Fineman JR, Morin FC 3rd, et al: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997; 336:605-610
329. Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336:597-604
330. Wung JT, James LS, Kilchevsky E, et al: Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics 1985; 76:488-494
331. Drummond WH, Gregory GA, Heymann MA, et al: The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 1981; 98:603-611
332. Drummond WH: Use of cardiotonic therapy in the management of infants with PPHN. Clin Perinatol 1984; 11:715-728
333. Gouyon JB, Françoise M: Vasodilators in persistent pulmonary hypertension of the newborn: A need for optimal appraisal of efficacy. Dev Pharmacol Ther 1992; 19:62-68
334. Meadow WL, Meus PJ: Hemodynamic consequences of tolazoline in neonatal group B streptococcal bacteremia: An animal model. Pediatr Res 1984; 18:960-965
335. Sandor GG, Macnab AJ, Akesode FA, et al: Clinical and echocardiographic evidence suggesting afterload reduction as a mechanism of action of tolazoline in neonatal hypoxemia. Pediatr Cardiol 1984; 5:93-99
336. Benitz WE, Malachowski N, Cohen RS, et al: Use of sodium nitroprusside in neonates: Efficacy and safety. J Pediatr 1985; 106:102-110
337. McNamara PJ, Laique F, Muang-In S, et al: Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006; 21:217-222
338. Bassler D, Choong K, McNamara P, et al: Neonatal persistent pulmonary hypertension treated with milrinone: Four case reports. Biol Neonate 2006; 89:1-5
339. Rashid N, Morin FC 3rd, Swartz DD, et al: Effects of prostacyclin and milrinone on pulmonary hemodynamics in newborn lambs with persistent pulmonary hypertension induced by ductal ligation. Pediatr Res 2006; 60:624-629
340. Concheiro Guisán A, Sousa Rouco C, Suárez Traba B, et al: [Inhaled iloprost: A therapeutic alternative for persistent pulmonary hypertension of the newborn]. An Pediatr (Barc) 2005; 63:175-176
341. Ehlen M, Wiebe B: Iloprost in persistent pulmonary hypertension of the newborn. Cardiol Young 2003; 13:361-363
342. Patole S, Lee J, Buettner P, et al: Improved oxygenation following adenosine infusion in persistent pulmonary hypertension of the newborn. Biol Neonate 1998; 74:345-350
343. Konduri GG, Garcia DC, Kazzi NJ, et al: Adenosine infusion improves oxygenation in term infants with respiratory failure. Pediatrics 1996; 97:295-300
344. Motti A, Tissot C, Rimensberger PC, et al: Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: A potential new drug for rescue therapy. Pediatr Crit Care Med 2006; 7:380-382
345. Ng C, Franklin O, Vaidya M, et al: Adenosine infusion for the management of persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 2004; 5:10-13
346. Bartlett RH, Roloff DW, Custer JR, et al: Extracorporeal life support: The University of Michigan experience. JAMA 2000; 283:904-908
347. Meyer DM, Jessen ME: Results of extracorporeal membrane oxygenation in neonates with sepsis. The Extracorporeal Life Support Organization experience. J Thorac Cardiovasc Surg 1995; 109:419-425
348. Bernbaum J, Schwartz IP, Gerdes M, et al: Survivors of extracorporeal membrane oxygenation at 1 year of age: The relationship of primary diagnosis with health and neurodevelopmental sequelae. Pediatrics 1995; 96(5 Pt 1):907-913
349. The collaborative UK ECMO (Extracorporeal Membrane Oxygenation) trial: Follow-up to 1 year of age. Pediatrics 1998; 101:E1
350. Meyer DM, Jessen ME: Results of extracorporeal membrane oxygenation in children with sepsis. The Extracorporeal Life Support Organization. Ann Thorac Surg 1997; 63:756-761
351. Goldman AP, Kerr SJ, Butt W, et al: Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997; 349:466-469
352. Beca J, Butt W: Extracorporeal membrane oxygenation for refractory septic shock in children. Pediatrics 1994; 93:726-729
353. Dalton HJ, Siewers RD, Fuhrman BP, et al: Extracorporeal membrane oxygenation for cardiac rescue in children with severe myocardial dysfunction. Crit Care Med 1993; 21:1020-1028
354. Hallin GW, Simpson SQ, Crowell RE, et al: Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996; 24:252-258
355. Crowley MR, Katz RW, Kessler R, et al: Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med 1998; 26:409-414
356. MacLaren G, Butt W, Best D, et al: Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatr Crit Care Med 2011; 12:133-136
357. Maclaren G, Butt W, Best D, et al: Extracorporeal membrane oxygenation for refractory septic shock in children: One institution's experience. Pediatr Crit Care Med 2007; 8:447-451
358. Bréchot N, Luyt CE, Schmidt M, et al: Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med 2013; 41:1616-1626
359. Smalley N, MacLaren G, Best D, et al: Outcomes in children with refractory pneumonia supported with extracorporeal membrane oxygenation. Intensive Care Med 2012; 38:1001-1007
360. Jeffers A, Gladwin MT, Kim-Shapiro DB: Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias. Free Radic Biol Med 2006; 41:1557-1565
361. Jackson EK, Koehler M, Mi Z, et al: Possible role of adenosine deaminase in vaso-occlusive diseases. J Hypertens 1996; 14:19-29
362. Lou S, MacLaren G, Best D, et al: Hemolysis in pediatric patients receiving centrifugal-pump extracorporeal membrane oxygenation: Prevalence, risk factors, and outcomes. Crit Care Med 2014; 42:1213-1220
363. Pfaender M: Hemodynamics in the extracorporeal aortic cannula: Review of factors affecting choice of the appropriate size. J Extracorp Tech 1981; 13:224-232
364. Mulholland JW, Massey W, Shelton JC: Investigation and quantification of the blood trauma caused by the combined dynamic forces experienced during cardiopulmonary bypass. Perfusion 2000; 15:485-494
365. Dellinger RP, Levy MM, Rhodes A, et al: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
366. Fortenberry JD, Paden ML, Goldstein SL: Acute kidney injury in children: An update on diagnosis and treatment. Pediatr Clin North Am 2013; 60:669-688
367. Sutherland SM, Zappitelli M, Alexander SR, et al: Fluid overload and mortality in children receiving continuous renal replacement therapy: The prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010; 55:316-325
368. Goldstein SL, Somers MJ, Baum MA, et al: Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005; 67:653-658
369. Bellomo R, Cass A, Cole L, et al; RENAL Replacement Therapy Study Investigators: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361:1627-1638
370. Van Wert R, Friedrich JO, Scales DC, et al; University of Toronto Acute Kidney Injury Research Group: High-dose renal replacement therapy for acute kidney injury: Systematic review and meta-analysis. Crit Care Med 2010; 38:1360-1369
371. Fortenberry JD, Paden ML: Extracorporeal therapies in the treatment of sepsis: Experience and promise. Semin Pediatr Infect Dis 2006; 17:72-79
372. Smith OP, White B, Vaughan D, et al: Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet 1997; 350:1590-1593
373. Ratanarat R, Brendolan A, Ricci Z, et al: Pulse high-volume hemofiltration in critically ill patients: A new approach for patients with septic shock. Semin Dial 2006; 19:69-74
374. Piccinni P, Dan M, Barbacini S, et al: Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006; 32:80-86
375. Bock KR: Renal replacement therapy in pediatric critical care medicine. Curr Opin Pediatr 2005; 17:368-371
376. Bridges BC, Hardison D, Pietsch J: A case series of the successful use of ECMO, continuous renal replacement therapy, and plasma exchange for thrombocytopenia-associated multiple organ failure. J Pediatr Surg 2013; 48:1114-1117
377. Szczepiorkowski ZM, Winters JL, Bandarenko N, et al; Apheresis Applications Committee of the American Society for Apheresis: Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25:83-177
378. Zhou F, Peng Z, Murugan R, et al: Blood purification and mortality in sepsis: A meta-analysis of randomized trials. Crit Care Med 2013; 41:2209-2220
379. De Simone N, Racsa L, Bevan S, et al: Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: A report of three cases. J Clin Apher 2014; 29:127-131
380. Demirkol D, Yildizdas D, Bayrakci B, et al; Turkish Secondary HLH/MAS Critical Care Study Group: Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: What is the treatment? Crit Care 2012; 16:R52
381. Qu L, Kiss JE, Dargo G, et al: Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange. J Clin Apher 2011; 26:208-213
382. Sevketoglu E, Yildizdas D, Horoz OO, et al: Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network. Pediatr Crit Care Med 2014; 15:e354-e359
383. Churchwell KB, McManus ML, Kent P, et al: Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia. J Clin Apher 1995; 10:171-177
384. van Deuren M, Frieling JT, van der Ven-Jongekrijg J, et al: Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange. Clin Infect Dis 1998; 26:918-923
385. van Deuren M, Santman FW, van Dalen R, et al: Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis 1992; 15:424-430
386. Yildirim I, Ceyhan M, Bayrakci B, et al: A case report of thrombocytopenia-associated multiple organ failure secondary to Salmonella enterica serotype Typhi infection in a pediatric patient: Successful treatment with plasma exchange. Ther Apher Dial 2010; 14:226-229
387. Nguyen TC, Han YY, Kiss JE, et al: Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 2008; 36:2878-2887
388. Long EJ, Taylor A, Delzoppo, et al: A randomised controlled trial of plasma filtration in severe paediatric sepsis. Crit Care Resusc 2013; 15:198-204
389. Hirabayashi K, Shiohara M, Saito S, et al: Polymyxin-direct hemoperfusion for sepsis-induced multiple organ failure. Pediatr Blood Cancer 2010; 55:202-205
390. Hirakawa E, Ibara S, Tokuhisa T, et al: Septic neonate rescued by polymyxin B hemoperfusion. Pediatr Int 2013; 55: e70-e72
391. Nakamura T, Sato E, Fujiwara N, et al: Polymyxin B-immobilized fiber hemoperfusion in a high school football player with septic shock caused by osteitis pubis. ASAIO J 2011; 57:470-472
392. Haque IU, Zaritsky AL: Analysis of the evidence for the lower limit of systolic and mean arterial pressure in children. Pediatr Crit Care Med 2007; 8:138-144